![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
G Lonart and KM Johnson
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, USA.
In this study we compared the effects of two nitrogen monoxide (NO) generators, hydroxylamine and S-nitroso-L-cysteine (NO-CYS), on hippocampal [3H]norepinephrine ([3H]NE) release. A 10-min incubation with hydroxylamine (3-3,000 microM) or NO-CYS (30-10,000 microM) induced a concentration-dependent increase in the basal [3H]NE efflux with EC50 values of approximately 100 microM and 1 mM, respectively. Reduced hemoglobin, a NO scavenger, blocked both hydroxylamine- and NO- CYS-evoked [3H]NE release. Long-term exposure (> or = 25 min) to 100 microM hydroxylamine, or to millimolar concentrations of NO-CYS, evoked a tetrodotoxin-insensitive [3H]NE release. However, a 10-min stimulation with either 100 microM hydroxylamine or 300 microM NO-CYS was sensitive to 0.5 microM tetrodotoxin, a voltage-sensitive sodium channel blocker. This suggested that under these conditions hydroxylamine and NO-CYS induce [3H]NE release indirectly in part, perhaps via releasing an excitatory neurotransmitter. Indeed, kynurenate, a nonselective ionotropic glutamate receptor antagonist, produced an 80% inhibition of the NO generator-evoked [3H]NE release. CGS 19755, a N-methyl-D-aspartate receptor antagonist, had no significant effect, whereas the alpha-amino-3-hydroxy-5-methylisoxazole- 4-propionic acid/kainate receptor antagonists, CNQX and GYKI 52446, inhibited the hydroxylamine response by 50%. In synaptosomes, a preparation in which synaptic interactions are nonsignificant, NO-CYS induced a dose-dependent release of both [3H]NE and [3H]glutamate. These data suggest that, in hippocampal slices, NO generators evoke [3H]NE release both directly from noradrenergic terminals and indirectly via releasing glutamate.
This article has been cited by other articles:
|
|
 |
|
  X. Li and J. C. Eisenach alpha 2A-Adrenoceptor Stimulation Reduces Capsaicin-Induced Glutamate Release from Spinal Cord Synaptosomes J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimoyama, N. Shimoyama, G.-M. Zhao, P. W. Schiller, and H. H. Szeto Antinociceptive and Respiratory Effects of Intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1]DALDA J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 364 - 371. [Abstract] [Full Text]
|
|
|
|
|
|
X. Li, G. Rose, A. Chiari, H.-L. Pan, J. R. Tobin, and J. C. Eisenach 6-NO2-Norepinephrine Increases Norepinephrine Release and Inhibits Norepinephrine Uptake in Rat Spinal Synaptosomes J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 895 - 899. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. S. Vizi Role of High-Affinity Receptors and Membrane Transporters in Nonsynaptic Communication and Drug Action in the Central Nervous System Pharmacol. Rev., March 1, 2000; 52(1): 63 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xu, C. Tong, H.-L. Pan, S. E. Cerda, and J. C. Eisenach Intravenous Morphine Increases Release of Nitric Oxide From Spinal Cord by an alpha -Adrenergic and Cholinergic Mechanism J Neurophysiol, October 1, 1997; 78(4): 2072 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Gironacci, P. S. Lorenzo, and E. Adler-Graschinsky Possible Participation of Nitric Oxide in the Increase of Norepinephrine Release Caused by Angiotensin Peptides in Rat Atria Hypertension, June 1, 1997; 29(6): 1344 - 1350. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
